arrow
D

Diya Surie

cdc
H指数:25
被引数:2,043

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Influenza vaccine effectiveness against influenza A-associated hospitalization and severe in-hospital outcomes among adults in the United States, 2024–2025

2024–2025年度美国成人人群中流感疫苗对流感A相关住院及院内严重结局的保护效果

2026-09-260
PRE
Genomic surveillance of human metapneumovirus in the United States, 2010–2025

2010–2025年美国人类偏肺病毒的基因组监测

2026-05-060
PRE
Incidence Rates of RSV-Associated Hospitalizations Among Adults in Middle Tennessee, United States, October 2022 Through September 2023

2022年10月至2023年9月美国中田纳西州成人RSV相关住院发生率

2025-08-250
OAAI
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults With Respiratory Syncytial Virus

成人呼吸道合胞病毒感染的多重共病模式与院内严重预后

2025-08-010
PRE
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024

疫苗对流感A(H1N1)、A(H3N2)和B相关住院的效力,美国,2023年9月1日至2024年5月31日

2025-04-080
PRE
Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination

与呼吸道合胞病毒疫苗接种相关的患者层面和社区层面特征

2025-04-010
OA
In Vitro Study Comparing SARS-CoV-2 Ancestral and Omicron Lineages Sequence & Neutralization Differences

体外研究比较SARS-CoV-2祖先和Omicron谱系序列与中和差异

2025-03-010
OAAI
A framework for monitoring RSV prevention product effectiveness in the United States

一个用于监测美国RSV预防产品有效性的框架

VACCINE
IF3.5
2025-01-010
PRE
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study

早期奥司他韦治疗对甲型流感住院成人患者的益处: 一项观察性研究

2024-11-281
OA
Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023

2022年9月-2023年8月,原始单价和二价新型冠状病毒肺炎疫苗对美国成人COVID-19-Associated住院和严重住院结局的有效性

2024-11-040
OA
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024

更新的2023-2024 (单价XBB.1.5) 新型冠状病毒肺炎接种SARS-CoV-2 Omicron XBB和BA.2.86/JN.1的有效性谱系住院和临床严重程度的比较-IVY Network,26家医院,2023年10月18日-2024 3月9日

2024-08-069
OA
Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves

在整个Delta到Omicron波中,美国循环和新兴SARS-CoV-2变体的抗原表征

2024-05-074
OAAI
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023

疫苗对甲型流感相关住院,器官衰竭和死亡的有效性: 美国,2022-2023

2023-12-0519
OA
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022

引入新型冠状病毒肺炎疫苗后,美国冠状病毒疾病2019 (新型冠状病毒肺炎) 住院成人严重程度和流行病学的变化,3月2021-2022年8月

2023-05-3125
OA
Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants

感染SARS-CoV-2 α,δ 和Omicron变体的患者的总和亚基因组RNA病毒载量

2023-03-086
OA